Omiya, Japan

Tomoyuki Ikemoto


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 24(Granted Patents)


Location History:

  • Ohmiya, JP (1989)
  • Omiya, JP (1990)

Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tomoyuki Ikemoto

Introduction

Tomoyuki Ikemoto is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid compounds. With a total of 2 patents, his work has garnered attention for its potential therapeutic applications.

Latest Patents

Ikemoto's latest patents include innovative compounds that exhibit anti-inflammatory activity. One of his notable inventions is a 21-alkoxysteroid compound represented by a specific formula, where R¹ is an alkyl group with 1 to 4 carbon atoms or a methylthiomethyl group, and R² is an alkanoyl group with 2 to 7 carbon atoms. This compound has shown promise in treating inflammation. Another significant patent involves 21-alkyl-, cycloalkyl-, or aryl-substituted thio steroids, which are represented by a general formula where R¹ can be an alkyl group with 1 to 6 carbon atoms, a cycloalkyl group, or a phenyl group, potentially leading to new therapeutic options.

Career Highlights

Throughout his career, Ikemoto has worked with reputable companies such as Jouveinal and Taisho Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ikemoto has collaborated with esteemed colleagues, including Morihiro Mitsukuchi and Kaoru Sota. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Tomoyuki Ikemoto's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in anti-inflammatory treatments and steroid compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…